https://www.fiercepharma.com/sponsored/reprogramming-immune-system-to-fight-cancerhttps://www.fiercepharma.com/sponsored/reprogramming-immune-system- Reprogramming the Immune System To Fight Cancer Sponsored by Immunomic Therapeutics, Inc. Nov 14, 2016 12:00am By Teri Heiland, Ph.D and Bill Watt, Ph.D. Cancer immunotherapy marks a turning ...
Clouds of pollen emanate from cedar trees in Sagamihara, Kanagawa Prefecture, in 2005. | KYODO LIFESTYLE When pollen attacks! Experts reveal new approaches to combating hay fever BY TOMOKO OTAKE ...
Immunomic is pleased to share that CEO Dr. Bill Hearl served as a panelist during The Washington Post’s Chasing Cancer Summit in Washington, D.C. on Tuesday, Dec. 7th. The event was focused ...
January 05, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces two additions to their Scientific Advisory Board. “We could not ...
Allergy treatments enter a new era — with a focus on stopping reactions before they start MEGHANA KESHAVAN @megkesh NOVEMBER 29, 2016 Allergy treatments haven’t advanced much in decades, even ...
April 27-28, 2017 Bethesda Marriott Conference Center Presented by the Maryland Technology Council, Bio+Tech17 reflects the changing landscape where life science and technology converge by bringing together more than 600 ...
ITI announced the issuance of a new United States Patent which extends ITI’s intellectual property portfolio covering their proprietary vectors, including ITI’s out-licensed investigational DNA vaccines. Specifically, U.S. Patent No. 9,499,589 ...
The Washington Business Journal article tells the story of the evolution of Immunomic Therapeutics and its strategy in applying LAMP-Vax in dierent disease areas. The article further highlights Immunomics partnering ...
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Paragon Bioservices, Inova, University System of Maryland and Medimmune/AstraZeneca. Maryland, Virginia, and Washington, ...
January 05, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces two additions to their Scientific Advisory Board. “We could not ...
TOKYO, Dec. 20, 2016 /PRNewswire/ -- Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas") and Immunomic Therapeutics, Inc. (Founder & CEO: William Hearl, Ph.D., "Immunomic Therapeutics") today announced that the ...
December 14, 2016 07:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces that C. Eric Winzer, M.B.A., currently serving Immunomic as Chief ...